ArticleCancer medicine2024

Surufatinib combined with transarterial embolization versus surufatinib monotherapy in patients with liver metastatic neuroendocrine tumors: Study protocol for a prospective, randomized, controlled trial.

Ruizhen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.